AMBER WALKER: Open Payments
NPI 1144940776 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 20 payments from 12 companies in 2025. Trend: 2023 $605 · 2024 $744 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| Tris Pharma Inc | 4 | $211 |
| Alkermes, Inc. | 3 | $211 |
| ABBVIE INC. | 4 | $112 |
| Janssen Pharmaceuticals, Inc | 1 | $95 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Bausch Health US, LLC | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Corium, LLC | 1 | $20 |
Products named: LYBALVI, VRAYLAR, INVEGA SUSTENNA, Dyanavel XR, Onyda XR, ABILIFY MAINTENA, APLENZIN, INGREZZA.
Industry payments across AZ — which companies pay providers there.
